Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment

CH Liu; CY Chen; WW Su; KC Tseng; CC Lo; CJ Liu; JJ Chen; CY Peng; YL Shih; SS Yang; CS Huang; KJ Huang; CY Chang; MC Tsai; Wei-Yu Kao; YJ Fang; PY Chen; PY Su; CW Tseng; JJ Huang; PL Lee; HC Lai; TY Hsieh; CH Chang; YJ Huang; FJ Lee; CC Chang; JH Kao

Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment

CH Liu , CY Chen , WW Su , KC Tseng , CC Lo , CJ Liu, JJ Chen , CY Peng, YL Shih, SS Yang, CS Huang, KJ Huang, CY Chang, MC Tsai , Wei-Yu Kao, YJ Fang, PY Chen, PY Su, CW Tseng, JJ HuangPL Lee, HC Lai, TY Hsieh, CH Chang, YJ Huang, FJ Lee, CC Chang, JH Kao

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Gut
Publication status	Published - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Liu , CH., Chen , CY., Su , WW., Tseng , KC., Lo , CC., Liu, CJ., Chen , JJ., Peng, CY., Shih, YL., Yang, SS., Huang, CS., Huang, KJ., Chang, CY., Tsai , MC., Kao, W.-Y., Fang, YJ., Chen, PY., Su, PY., Tseng, CW., ... Kao , JH. (2021). Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment. Gut.

Liu , CH, Chen , CY, Su , WW, Tseng , KC, Lo , CC, Liu, CJ, Chen , JJ, Peng, CY, Shih, YL, Yang, SS, Huang, CS, Huang, KJ, Chang, CY, Tsai , MC, Kao, W-Y, Fang, YJ, Chen, PY, Su, PY, Tseng, CW, Huang, JJ, Lee, PL, Lai, HC, Hsieh, TY, Chang, CH, Huang, YJ, Lee, FJ, Chang, CC & Kao , JH 2021, 'Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment', Gut.

@article{00fba7c7385545d884c5269efcc77dfe,

title = "Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment",

author = "CH Liu and CY Chen and WW Su and KC Tseng and CC Lo and CJ Liu and JJ Chen and CY Peng and YL Shih and SS Yang and CS Huang and KJ Huang and CY Chang and MC Tsai and Wei-Yu Kao and YJ Fang and PY Chen and PY Su and CW Tseng and JJ Huang and PL Lee and HC Lai and TY Hsieh and CH Chang and YJ Huang and FJ Lee and CC Chang and JH Kao",

year = "2021",

language = "English",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment

AU - Liu , CH

AU - Chen , CY

AU - Su , WW

AU - Tseng , KC

AU - Lo , CC

AU - Liu, CJ

AU - Chen , JJ

AU - Peng, CY

AU - Shih, YL

AU - Yang, SS

AU - Huang, CS

AU - Huang, KJ

AU - Chang, CY

AU - Tsai , MC

AU - Kao, Wei-Yu

AU - Fang, YJ

AU - Chen, PY

AU - Su, PY

AU - Tseng, CW

AU - Huang, JJ

AU - Lee, PL

AU - Lai, HC

AU - Hsieh, TY

AU - Chang, CH

AU - Huang, YJ

AU - Lee, FJ

AU - Chang, CC

AU - Kao , JH

PY - 2021

Y1 - 2021

M3 - Article

SN - 0017-5749

JO - Gut

JF - Gut

ER -